407 related articles for article (PubMed ID: 34067321)
21. New perspective for an old antidiabetic drug: metformin as anticancer agent.
Leone A; Di Gennaro E; Bruzzese F; Avallone A; Budillon A
Cancer Treat Res; 2014; 159():355-76. PubMed ID: 24114491
[TBL] [Abstract][Full Text] [Related]
22. Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer.
Samuel SM; Varghese E; Kubatka P; Triggle CR; Büsselberg D
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31835318
[TBL] [Abstract][Full Text] [Related]
23. Diabetes mellitus and the risk of cancer.
Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
[TBL] [Abstract][Full Text] [Related]
24. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.
Romero R; Erez O; Hüttemann M; Maymon E; Panaitescu B; Conde-Agudelo A; Pacora P; Yoon BH; Grossman LI
Am J Obstet Gynecol; 2017 Sep; 217(3):282-302. PubMed ID: 28619690
[TBL] [Abstract][Full Text] [Related]
25. An overview of metformin in the treatment of type 2 diabetes mellitus.
Davidson MB; Peters AL
Am J Med; 1997 Jan; 102(1):99-110. PubMed ID: 9209206
[TBL] [Abstract][Full Text] [Related]
26. [Metformin--new treatment strategies for gynecologic neoplasms].
Milewicz T; Kiałka M; Mrozińska S; Ociepka A; Krzysiek J
Przegl Lek; 2013; 70(2):81-4. PubMed ID: 23879009
[TBL] [Abstract][Full Text] [Related]
27. Molecular targets of metformin antitumor action.
Sośnicki S; Kapral M; Węglarz L
Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
[TBL] [Abstract][Full Text] [Related]
28. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
29. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach.
Nadeau DA
Postgrad Med; 2013 May; 125(3):112-26. PubMed ID: 23748512
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
[TBL] [Abstract][Full Text] [Related]
31. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.
Vrachnis N; Iavazzo C; Iliodromiti Z; Sifakis S; Alexandrou A; Siristatidis C; Grigoriadis C; Botsis D; Creatsas G
Arch Gynecol Obstet; 2016 Feb; 293(2):239-46. PubMed ID: 26338721
[TBL] [Abstract][Full Text] [Related]
32. Antidiabetic effect of mangiferin in combination with oral hypoglycemic agents metformin and gliclazide.
Sekar V; Mani S; Malarvizhi R; Nithya P; Vasanthi HR
Phytomedicine; 2019 Jun; 59():152901. PubMed ID: 30981189
[TBL] [Abstract][Full Text] [Related]
33. Pioglitazone, rosiglitazone, and rosiglitazone + metformin: new drugs. Glitazone + oral antidiabetic combination: inadequately evaluated.
Prescrire Int; 2005 Aug; 14(78):133-9. PubMed ID: 16106595
[TBL] [Abstract][Full Text] [Related]
34. Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes.
Tan BX; Yao WX; Ge J; Peng XC; Du XB; Zhang R; Yao B; Xie K; Li LH; Dong H; Gao F; Zhao F; Hou JM; Su JM; Liu JY
Cancer; 2011 Nov; 117(22):5103-11. PubMed ID: 21523768
[TBL] [Abstract][Full Text] [Related]
35. Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect.
Zhu L; Yang K; Ren Z; Yin D; Zhou Y
Transl Oncol; 2024 Jun; 44():101945. PubMed ID: 38555742
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
37. [Advances of the anti-tumor research of metformin].
Xue CJ; Liu KX
Yao Xue Xue Bao; 2015 Oct; 50(10):1210-6. PubMed ID: 26837164
[TBL] [Abstract][Full Text] [Related]
38. Repurposing metformin for the treatment of gastrointestinal cancer.
Cunha Júnior AD; Bragagnoli AC; Costa FO; Carvalheira JBC
World J Gastroenterol; 2021 May; 27(17):1883-1904. PubMed ID: 34007128
[TBL] [Abstract][Full Text] [Related]
39. Combination therapy with insulin and metformin.
Hermann LS
Endocr Pract; 1998; 4(6):404-12. PubMed ID: 15251717
[TBL] [Abstract][Full Text] [Related]
40. Metformin: From Diabetes to Cancer-Unveiling Molecular Mechanisms and Therapeutic Strategies.
Amengual-Cladera E; Morla-Barcelo PM; Morán-Costoya A; Sastre-Serra J; Pons DG; Valle A; Roca P; Nadal-Serrano M
Biology (Basel); 2024 Apr; 13(5):. PubMed ID: 38785784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
